vistide
gilead sciences international limited - cidofovir - cytomegalovirus retinitis - antivirals for systemic use - vistide is indicated for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome (aids) and without renal dysfunction. vistide should be used only when other agents are considered unsuitable.,
viread 245mg tablets
gilead sciences international ltd - tenofovir disoproxil - tablet - 245mg
viread 33mgg granules
gilead sciences international ltd - tenofovir disoproxil fumarate - granules - 33mg/1gram
vitekta
gilead sciences international ltd - elvitegravir - hiv infections - antivirals for systemic use - vitekta co-administered with a ritonavir-boosted protease inhibitor and with other antiretroviral agents, is indicated for the treatment of human-immunodeficiency-virus-1 (hiv-1) infection in adults who are infected with hiv-1 without known mutations associated with resistance to elvitegravir.
hepsera 10mg tablets
gilead sciences international ltd - adefovir dipivoxil - tablet - 10mg
viread 123mg tablets
gilead sciences international ltd - tenofovir disoproxil fumarate - tablet - 123mg
viread 163mg tablets
gilead sciences international ltd - tenofovir disoproxil fumarate - tablet - 163mg
viread 204mg tablets
gilead sciences international ltd - tenofovir disoproxil fumarate - tablet - 204mg
atripla
gilead sciences israel ltd - efavirenz; emtricitabine; tenofovir disoproxil as - film coated tablets - tenofovir disoproxil as 245 mg; emtricitabine 200 mg; efavirenz 600 mg - tenofovir disoproxil - atripla is indicated for use alone as a complete regimen or in combination with other antiretroviral agents for the treatment of hiv-1 infection in adults.
ambisome liposomal amphotericin b 50 milligram concentrate for soln for inf
gilead sciences international - amphotericin b - concentrate for soln for inf - 50 milligram - antibiotics